China Universal Asset Management Co. Ltd. Buys 3,416 Shares of IQVIA Holdings Inc. (NYSE:IQV)

China Universal Asset Management Co. Ltd. grew its stake in IQVIA Holdings Inc. (NYSE:IQV) by 4,066.7% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 3,500 shares of the medical research company’s stock after purchasing an additional 3,416 shares during the period. China Universal Asset Management Co. Ltd.’s holdings in IQVIA were worth $829,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently modified their holdings of IQV. Versant Capital Management Inc boosted its stake in shares of IQVIA by 733.3% during the second quarter. Versant Capital Management Inc now owns 125 shares of the medical research company’s stock valued at $26,000 after purchasing an additional 110 shares during the period. Opal Wealth Advisors LLC purchased a new stake in shares of IQVIA during the second quarter valued at $27,000. Park Place Capital Corp purchased a new stake in shares of IQVIA during the third quarter valued at $28,000. Itau Unibanco Holding S.A. purchased a new stake in shares of IQVIA during the second quarter valued at $29,000. Finally, International Assets Investment Management LLC purchased a new stake in shares of IQVIA during the second quarter valued at $32,000. 89.62% of the stock is owned by institutional investors.

Insider Activity

In other news, insider Eric Sherbet sold 1,300 shares of the company’s stock in a transaction dated Tuesday, August 27th. The shares were sold at an average price of $246.33, for a total transaction of $320,229.00. Following the transaction, the insider now owns 19,536 shares in the company, valued at $4,812,302.88. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Corporate insiders own 1.60% of the company’s stock.

IQVIA Stock Performance

IQV opened at $216.34 on Wednesday. IQVIA Holdings Inc. has a 52-week low of $167.42 and a 52-week high of $261.73. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 1.80. The company has a market cap of $39.44 billion, a P/E ratio of 28.10, a price-to-earnings-growth ratio of 2.09 and a beta of 1.49. The firm’s 50-day moving average price is $236.50 and its 200-day moving average price is $230.16.

Wall Street Analyst Weigh In

Several analysts recently weighed in on the company. Argus upgraded IQVIA to a “strong-buy” rating in a report on Wednesday, July 31st. Barclays decreased their price objective on IQVIA from $275.00 to $260.00 and set an “overweight” rating for the company in a report on Tuesday, October 15th. StockNews.com upgraded IQVIA from a “hold” rating to a “buy” rating in a report on Wednesday. Truist Financial decreased their price objective on IQVIA from $300.00 to $286.00 and set a “buy” rating for the company in a report on Monday, October 14th. Finally, JPMorgan Chase & Co. decreased their price objective on IQVIA from $288.00 to $279.00 and set an “overweight” rating for the company in a report on Wednesday, October 23rd. Four investment analysts have rated the stock with a hold rating, thirteen have given a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, IQVIA currently has a consensus rating of “Moderate Buy” and a consensus target price of $267.27.

IQVIA Company Profile

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.